| Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD) M Hemmati, S Kashanipoor, P Mazaheri, F Alibabaei, A Babaeizad, S Asli, ... Life Sciences 329, 121947, 2023 | 46 | 2023 |
| Reemergence of Mycoplasma pneumoniae disease: pathogenesis and new approaches H Tahmasebi, A Babaeizad, M Mohammadlou, F Alibabaei, ... Microbial pathogenesis, 106944, 2024 | 4 | 2024 |
| From Cure to Crisis: Understanding the Evolution of Antibiotic-Resistant Bacteria in Human Microbiota H Tahmasebi, N Arjmand, M Monemi, A Babaeizad, F Alibabaei, ... Biomolecules 15 (1), 93, 2025 | 2 | 2025 |
| Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies H Farhadi Rad, H Tahmasebi, S Javani, M Hemati, D Zakerhamidi, ... Biomedicines 12 (12), 2776, 2024 | 2 | 2024 |
| Cefiderocol in Combating Carbapenem-Resistant Acinetobacter baumannii: Action and Resistance B Yousefi, S Kashanipoor, P Mazaheri, F Alibabaei, A Babaeizad, S Asli, ... Biomedicines 12 (11), 2532, 2024 | 1 | 2024 |
| The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases M Eslami, F Alibabaei, A Babaeizad, SZ Banihashemian, M Mazandarani, ... Biomolecules 14 (11), 1345, 2024 | | 2024 |